Cancer Proteomics From Bench to Bedside /
Over the past 20 years or so, there have been tremendous advances in our understanding of how normal cells transform to cancer and the importance of signaling pathways in cancer initiation and progression. Therefore, proteomics technologies must be improved for more global analysis of protein conten...
Saved in:
| 企業作者: | |
|---|---|
| 其他作者: | |
| 格式: | 電子 電子書 |
| 語言: | English |
| 出版: |
Totowa, NJ :
Humana Press : Imprint: Humana,
2008.
|
| 版: | 1st ed. 2008. |
| 叢編: | Cancer Drug Discovery and Development,
|
| 主題: | |
| 在線閱讀: | https://doi.org/10.1007/978-1-59745-169-7 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|
書本目錄:
- Proteomics Technologies
- Current and Emerging Mass Spectrometry Instrumentation and Methods for Proteomic Analyses
- Cell Signaling Proteomics
- Integration of Genomics and Proteomics in Dissecting p53 Signaling
- Proteomic Profiling of Tyrosine Kinases as Pharmacological Endpoints for Targeted Cancer Therapy
- Tumor Proteomics
- Oncoproteomics for Personalized Management of Cancer
- Application of Serum and Tissue Proteomics to Understand and Detect Solid Tumors
- Insight on Renal Cell Carcinoma Proteome
- Proteomics in Lung Cancer
- Proteomic Strategies of Therapeutic Individualization and Target Discovery in Acute Myeloid Leukemia
- New Tumor Biomarkers
- Bioinformatics and Regulatory Aspects of Proteomics
- Annotating the Human Proteome
- Regulatory Issues in the Co-Development of Oncology Drugs and Proteomic Tests: An Overview.